Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine

Livrables

Update of dissemination and communication measures

This document summarises the updated communication and dissemination measuresNow also including i the poster or Ppt presentations given at international conferences iiscientific publications iii nonconfidential data package ivinternational symposium minutes

Dissemination and Communication Measures

This report summarises all dissemination and communication measures established during the first year: (i) project website, (ii) press release at time of kick-off meeting, (iii) social media, (iv) PowerPoint template with logo, (v) provisional MOOC.

Publications

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate

Auteurs: Lorena Sanchez-Felipe, Thomas Vercruysse, Sapna Sharma, Ji Ma, Viktor Lemmens, Dominique Van Looveren, Mahadesh Prasad Arkalagud Javarappa, Robbert Boudewijns, Bert Malengier-Devlies, Laurens Liesenborghs, Suzanne J. F. Kaptein, Carolien De Keyzer, Lindsey Bervoets, Sarah Debaveye, Madina Rasulova, Laura Seldeslachts, Li-Hsin Li, Sander Jansen, Michael Bright Yakass, Babs E. Verstrepen, Kinga P. B
Publié dans: Nature, Numéro 590/7845, 2021, Page(s) 320-325, ISSN 0028-0836
Éditeur: Nature Publishing Group
DOI: 10.1038/s41586-020-3035-9

A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies

Auteurs: Niraj Mishra, Robbert Boudewijns, Michael Alexander Schmid, Rafael Elias Marques, Sapna Sharma, Johan Neyts, Kai Dallmeier
Publié dans: mBio, Numéro 11/2, 2020, ISSN 2161-2129
Éditeur: American Society for Microbiology
DOI: 10.1128/mbio.02494-19

STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters

Auteurs: Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, Johan Van Weyenbergh, Carolien De Keyzer, Lindsey Bervoets, Sapna Sharma, Laurens Liesenborghs, Ji Ma, Sander Jansen, Dominique Van Looveren, Thomas Vercruysse, Xinyu Wang, Dirk Jochmans, Erik Martens, Kenny Roose, Dorien De Vlieger, Bert Schepens, Tina Van Buyten, Sofie Jacobs, Yanan Li
Publié dans: Nature Communications, Numéro 11/1, 2020, Page(s) 5838, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-020-19684-y

Comparing immunogenicity and protective efficacy of the yellow fever 17D vaccine in mice

Auteurs: Ji Ma; Robbert Boudewijns; Lorena Sanchez-Felipe; Niraj Mishra; Niraj Mishra; Thomas Vercruysse; Dieudonné Buh Kum; Hendrik Jan Thibaut; Johan Neyts; Johan Neyts; Kai Dallmeier; Kai Dallmeier
Publié dans: Emerging Microbes & Infections, Numéro 1, 2021, Page(s) 2279-2290, ISSN 2222-1751
Éditeur: Nature Publishing Group
DOI: 10.1080/22221751.2021.2008772

Towards rabies elimination in the Asia-Pacific region: From theory to practice

Auteurs: Charles E. Rupprecht, Bernadette Abela-Ridder, Ronello Abila, Anna Charinna Amparo, Ashley Banyard, Jesse Blanton, Karoon Chanachai, Kai Dallmeier, Katinka de Balogh, Victor Del Rio Vilas, Hildegund Ertl, Conrad Freuling, Richard Hill, Guy Houillon, Miia Jakava-Viljanen, Suwicha Kasemsuwan, Jacques Léchenet, Louis Nel, Pranee Panichabhongse, Sira Abdul Rahman, Terapong Tantawichien, Joris Vandepu
Publié dans: Biologicals, Numéro 64, 2020, Page(s) 83-95, ISSN 1045-1056
Éditeur: Academic Press
DOI: 10.1016/j.biologicals.2020.01.008

Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine

Auteurs: Sapna Sharma, Michael A. Schmid, Lorena Sanchez Felipe, Jana Grenelle, Suzanne J.F. Kaptein, Lotte Coelmont, Johan Neyts, Kai Dallmeier
Publié dans: Human Vaccines & Immunotherapeutics, Numéro 16/9, 2020, Page(s) 2196-2203, ISSN 2164-5515
Éditeur: Landes Bioscience
DOI: 10.1080/21645515.2020.1765621

Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe

Auteurs: Juan E. Echevarría, Ashley C. Banyard, Lorraine M. McElhinney, Anthony R. Fooks
Publié dans: Viruses, Numéro 11/10, 2019, Page(s) 892, ISSN 1999-4915
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v11100892

MALT1 Controls Attenuated Rabies Virus by Inducing Early Inflammation and T Cell Activation in the Brain

Auteurs: E. Kip, J. Staal, L. Verstrepen, H. G. Tima, S. Terryn, M. Romano, K. Lemeire, V. Suin, A. Hamouda, M. Kalai, R. Beyaert, S. Van Gucht
Publié dans: Journal of Virology, Numéro 92/8, 2018, ISSN 0022-538X
Éditeur: American Society for Microbiology
DOI: 10.1128/JVI.02029-17

Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses

Auteurs: Jennifer Evans, Guanghui Wu, David Selden, Hubert Buczkowski, Leigh Thorne, Anthony Fooks, Ashley Banyard
Publié dans: Viruses, Numéro 10/3, 2018, Page(s) 130, ISSN 1999-4915
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v10030130

A yellow fever–Zika chimeric virus vaccine candidate protects against Zika infection and congenital malformations in mice

Auteurs: Dieudonné B. Kum, Niraj Mishra, Robbert Boudewijns, Ivan Gladwyn-Ng, Christian Alfano, Ji Ma, Michael A. Schmid, Rafael E. Marques, Dominique Schols, Suzanne Kaptein, Laurent Nguyen, Johan Neyts, Kai Dallmeier
Publié dans: npj Vaccines, Numéro 3/1, 2018, ISSN 2059-0105
Éditeur: Springer Nature
DOI: 10.1038/s41541-018-0092-2

Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS

Auteurs: Samuel P. Smith, Guanghui Wu, Anthony R. Fooks, Julian Ma, Ashley C. Banyard
Publié dans: Journal of General Virology, Numéro 100/8, 2019, Page(s) 1171-1186, ISSN 0022-1317
Éditeur: Society for General Microbiology
DOI: 10.1099/jgv.0.001269

Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus

Auteurs: Ashley C. Banyard, David Selden, Guanghui Wu, Leigh Thorne, Daisy Jennings, Denise Marston, Stefan Finke, Conrad M. Freuling, Thomas Müller, Juan E. Echevarría, Anthony R. Fooks
Publié dans: Journal of General Virology, Numéro 99/12, 2018, Page(s) 1590-1599, ISSN 0022-1317
Éditeur: Society for General Microbiology
DOI: 10.1099/jgv.0.001068

Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU

Auteurs: Rebecca Shipley, Edward Wright, David Selden, Guanghui Wu, James Aegerter, Anthony R Fooks, Ashley C Banyard
Publié dans: Tropical Medicine and Infectious Disease, Numéro 4/1, 2019, Page(s) 31, ISSN 2414-6366
Éditeur: Basel
DOI: 10.3390/tropicalmed4010031

Limited evolution of the yellow fever virus 17d in a mouse infection model

Auteurs: Dieudonné Buh Kum, Niraj Mishra, Bram Vrancken, Hendrik Jan Thibaut, Annelies Wilder-Smith, Philippe Lemey, Johan Neyts, Kai Dallmeier
Publié dans: Emerging Microbes & Infections, Numéro 8/1, 2019, Page(s) 1734-1746, ISSN 2222-1751
Éditeur: Nature Publishing Group
DOI: 10.1080/22221751.2019.1694394

A chimeric yellow fever-Zika virus vaccine candidate fully protects against yellow fever virus infection in mice

Auteurs: Dieudonné Buh Kum, Robbert Boudewijns, Ji Ma, Niraj Mishra, Dominique Schols, Johan Neyts, Kai Dallmeier
Publié dans: Emerging Microbes & Infections, Numéro 9/1, 2020, Page(s) 520-533, ISSN 2222-1751
Éditeur: Nature Publishing Group
DOI: 10.1080/22221751.2020.1730709

Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus

Auteurs: Rebecca Shipley, Edward Wright, Fabian Z. X. Lean, David Selden, Daniel L. Horton, Anthony R. Fooks, Ashley C. Banyard
Publié dans: Viruses, Numéro 13/5, 2021, Page(s) 947, ISSN 1999-4915
Éditeur: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/v13050947

Droits de propriété intellectuelle

CHIMERIC FLAVIVIRUS VACCINES

Numéro de demande/publication: 20 18077156
Date: 2018-10-05

CHIMERIC YELLOW FEVER ZIKA VIRUS STRAIN

Numéro de demande/publication: 20 18077167
Date: 2018-10-05

CHIMERIC YELLOW FEVER ZIKA VIRUS STRAIN

Numéro de demande/publication: 20 18077167
Date: 2018-10-05

CHIMERIC YELLOW FEVER ZIKA VIRUS STRAIN

Numéro de demande/publication: 20 18077167
Date: 2018-10-05

CHIMERIC FLAVIVIRUS VACCINES

Numéro de demande/publication: 20 18077156
Date: 2018-10-05

CHIMERIC FLAVIVIRUS VACCINES

Numéro de demande/publication: 20 18077156
Date: 2018-10-05

Livrables

Publications

Droits de propriété intellectuelle

Partager cette page

Télécharger